Why Bristol-Myers Squibb is making a big bet its approach to treating lung cancer is the right one – Business Insider
Business Insider |
Why Bristol-Myers Squibb is making a big bet its approach to treating lung cancer is the right one
Business Insider A new batch of data on Monday showed how immunotherapy, a new kind of cancer treatment that harnesses the body's immune system, works in lung cancer patients. Among the data were results on how Bristol-Myers Squibb's combination of two immunotherapy … Global Immunotherapy Drugs Market 2018 Review- Eli Lilly, Merck-Pfizer, Bristol Myers Squibb, Dendreon (Valeant … |
